Renal Denervation in Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.
Also called NCT01570777
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 121 participants
- Registry
-
NCT01570777
-
- Other papers using this trial's data
- Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial
- Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial
- Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
- Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT01570777. Randomized; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Denervation in Hypertension
- Acronym
- DENER-HTN
- Condition
- Hypertension, Resistant to Conventional Therapy
- Condition
- Renal Denervation
- Intervention (Procedure)
- renal denervation and optimized medication regimen
- Intervention (Procedure)
- optimized medication regimen
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Ministry of Health, France
Record details
- Record id
cardio:ct-nct01570777- Content hash
0790cf3819f273e0a76ed01d5877e85ef205cd9f98ee52980a09a843ba2c48cb